RecruitingNCT06898606
Psilocybin mushrooms with or without fluoxetine for difficult-to-treat depression
About this title
Read the official source — NCT06898606Medication studyAges 25–65Brazil
Understand this study
Who could participate?
Listed age limits: 25 years to 65 years.
- Listed locations
- Foz do IguaçuSee all locations and recruitment
- Study phase
- Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: September 5, 2024
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 24
- Sponsor
- Federal University of Latin American Integration
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Behavioural, Drug
- Study phase
- Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- Brazil
- Age range
- From 25 Years to 65 Years
- Official registry ID
- NCT06898606
- Official title
Show the full official title
Psilocybe Cubensis Mushrooms With or Without Fluoxetine for Refractory Depression
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Foz do Iguaçu
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Federal University of Latin American Integration, a university.
Does this study involve medication?
Yes. The study involves medication, including Psilocybin and Psilocyn, Placebo and Fluoxetine.
Who can participate?
Listed age limits: 25 years to 65 years.
Is this study still recruiting?
The registry lists this study as recruiting.
